DOJ & FDA Vape Raids: Impact on Retailers & Distributors Token of Trust The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York When will the FDA reclassify BPC 157 to Category 1 Octagon AI FDA to weigh easing limits on unproven peptides